KATRISA BRITTON: Open Payments
NPI 1639727381 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,423 in 220 payments from 12 companies in 2025. Trend: 2023 $5,603 · 2024 $5,047 · 2025 $4,423
Food & beverage: $4,423
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 39 | $734 |
| Neurocrine BioSciences, Inc. | 41 | $617 |
| Axsome Therapeutics, Inc. | 27 | $562 |
| Teva Pharmaceuticals USA, Inc. | 36 | $527 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $462 |
| E.R. Squibb & Sons, L.L.C. | 15 | $390 |
| Otsuka America Pharmaceutical, Inc. | 9 | $295 |
| Lundbeck LLC | 14 | $287 |
| Alkermes, Inc. | 12 | $276 |
| Vanda Pharmaceuticals Inc. | 8 | $143 |
Products named: INGREZZA, Auvelity, REXULTI, CAPLYTA, SPRAVATO, COBENFY, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
